Slate Medicines, a new Raleigh biotechnology company developing treatments for migraine and headache disorders, has announced ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

Slate Medicines’ antibody drug is designed to block PACAP, a protein associated with migraines.

For Cherise Irons, chocolate, red wine, and aged cheeses are dangerous. So are certain sounds, perfumes and other strong scents, cold weather, and thunderstorms. Stress and lack of sleep, too. She ...

Decreased tear levels of CGRP and SP correlate with dry eye disease severity and symptoms. Study involved 12 healthy volunteers and 16 DED patients, highlighting significant neuropeptide level ...

According to current data, migraines are one of the most common neurological disorders worldwide and in the United States. Worldwide, migraines affect about 40% of the population (3.1 billion people).